Mirum Pharmaceuticals, Inc. (MIRM)
91.68
+0.64
(+0.70%)
USD |
NASDAQ |
Jan 20, 16:00
92.00
+0.32
(+0.34%)
After-Hours: 16:58
Mirum Pharmaceuticals Shareholders Equity (Quarterly): 292.05M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 92.80B |
| XOMA Royalty Corp. | 107.96M |
| Arcutis Biotherapeutics, Inc. | 158.07M |
| Recursion Pharmaceuticals, Inc. | 1.047B |
| Insmed, Inc. | 945.57M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 785.12M |
| Total Liabilities (Quarterly) | 493.07M |
| Debt to Equity Ratio | 1.092 |
| Current Ratio | 3.309 |
| Net Debt Paydown Yield | -0.01% |